Session XI: Mantle Cell Lymphoma 

Session Chairs: Kami J. Maddocks, MD and Brad Kahl, MD

Maximizing the Role of BTK Inhibition in MCL | Yucai Wang, MD, PhD | Mayo Clinic Rochester, Rochester, Minnesota, USA

Is There Still a Role for Transplant in MCL? | Brad Kahl, MD | Washington University, St. Louis, Missouri, USA

Novel Treatments in the Pipeline for MCL | Preetesh Jain, MD, DM, PhD | Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, USA

Risk-Based Strategies for MCL: From Watch and Wait to High Intensity | Kami J. Maddocks, MD | Ohio State University, Columbus, Ohio, USA

Oral Abstract | TBD | Speaker | Affiliation